Citation: | Shen Conghuan, Wang Zhengxin. Liver transplantation for inherited metabolic liver diseases[J]. ORGAN TRANSPLANTATION, 2024, 15(2): 178-184. doi: 10.3969/j.issn.1674-7445.2023212 |
[1] |
DE BOER L, CAMBI A, VERHAGEN LM, et al. Clinical and biochemical footprints of inherited metabolic diseases. XII. immunological defects[J]. Mol Genet Metab, 2023, 139(1): 107582. DOI: 10.1016/j.ymgme.2023.107582.
|
[2] |
DUNLEA E, CRUSHELL E, COTTER M, et al. Clinical and biochemical footprints of inherited metabolic disease. XVI. hematological abnormalities[J]. Mol Genet Metab, 2023, 140(4): 107735. DOI: 10.1016/j.ymgme.2023.107735.
|
[3] |
库尔班江·阿布都西库尔, 王建设. 遗传代谢性疾病与肝移植[J]. 中华肝脏病杂志, 2019, 27(3): 166-171. DOI: 10.3760/cma.j.issn.1007-3418.2019.03.002.
KUERBANJIANG ABDXKE, WANG JS. Inherited metabolic diseases and liver transplantation[J]. Chin J Hepatol, 2019, 27(3): 166-171. DOI: 10.3760/cma.j.issn.1007-3418.2019.03.002.
|
[4] |
夏强, 朱欣烨. 儿童肝移植发展现状及展望[J]. 临床小儿外科杂志, 2022, 21(5): 401-404. DOI: 10.3760/cma.j.cn101785-202202028-001.
XIA Q, ZHU XY. Current development and future outlook of pediatric liver transplantation[J]. J Clin Pediatr Surg, 2022, 21(5): 401-404. DOI: 10.3760/cma.j.cn101785-202202028-001.
|
[5] |
MCKIERNAN PJ, GANOZA A, SQUIRES JE, et al. Evolving trends in liver transplant for metabolic liver disease in the United States[J]. Liver Transpl, 2019, 25(6): 911-921. DOI: 10.1002/lt.25433.
|
[6] |
DE VILLE DE GOYET J, BAUMANN U, KARAM V, et al. European Liver Transplant Registry: donor and transplant surgery aspects of 16, 641 liver transplantations in children[J]. Hepatology, 2022, 75(3): 634-645. DOI: 10.1002/hep.32223.
|
[7] |
SMITH SK, MILOH T. Pediatric liver transplantation[J]. Clin Liver Dis, 2022, 26(3): 521-535. DOI: 10.1016/j.cld.2022.03.010.
|
[8] |
TESTINO G, PELLICANO R. Corrected and republished from: metabolic associated liver disease[J]. Panminerva Med, 2023, 65(3): 391-399. DOI: 10.23736/S0031-0808.23.04850-4.
|
[9] |
CHINSKY JM, SINGH R, FICICIOGLU C, et al. Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendations[J]. Genet Med, 2017, 19(12). DOI: 10.1038/gim.2017.101.
|
[10] |
LIU Y, LUO Y, XIA L, et al. Living-donor liver transplantation for children with tyrosinemia type I[J]. J Dig Dis, 2020, 21(3): 189-194. DOI: 10.1111/1751-2980.12846.
|
[11] |
GARCÍA VEGA M, ANDRADE JD, MORAIS A, et al. Urea cycle disorders and indications for liver transplantation[J]. Front Pediatr, 2023, 11: 1103757. DOI: 10.3389/fped.2023.1103757.
|
[12] |
KIDO J, MATSUMOTO S, HÄBERLE J, et al. Role of liver transplantation in urea cycle disorders: report from a nationwide study in Japan[J]. J Inherit Metab Dis, 2021, 44: 1311-1322. DOI: 10.1002/jimd.12415.
|
[13] |
JIANG YZ, ZHOU GP, WU SS, et al. Safety and efficacy of liver transplantation for methylmalonic acidemia: a systematic review and meta-analysis[J]. Transplant Rev, 2021, 35(1): 100592. DOI: 10.1016/j.trre.2020.100592.
|
[14] |
CURNOCK R, HEATON ND, VILCA-MELENDEZ H, et al. Liver transplantation in children with propionic acidemia: medium-term outcomes[J]. Liver Transpl, 2020, 26(3): 419-430. DOI: 10.1002/lt.25679.
|
[15] |
ARAS A, AVANAZ A, INAN AYDEMIR N, et al. Long-term results of liver transplantation for maple syrup urine disease: a single-center experience in Turkey[J]. Pediatr Transplant, 2023, 27(3): e14464. DOI: 10.1111/petr.14464.
|
[16] |
KIDO J, HÄBERLE J, SUGAWARA K, et al. Clinical manifestation and long-term outcome of citrin deficiency: report from a nationwide study in Japan[J]. J Inher Metab Disea, 2022, 45(3): 431-444. DOI: 10.1002/jimd.12483.
|
[17] |
BEYZAEI Z, SHAMSAEEFAR A, KAZEMI K, et al. Liver transplantation in glycogen storage disease: a single-center experience[J]. Orphanet J Rare Dis, 2022, 17(1): 127. DOI: 10.1186/s13023-022-02284-y.
|
[18] |
WRIGHT TLF, UMAÑA LA, RAMIREZ CM. Update on glycogen storage disease: primary hepatic involvement[J]. Curr Opin Pediatr, 2022, 34(5): 496-502. DOI: 10.1097/MOP.0000000000001158.
|
[19] |
张磊, 宋少华, 傅志仁. 肝移植治疗家族性高胆固醇血症的临床研究进展[J]. 中华器官移植杂志, 2023, 44(2): 112-116. DOI: 10.3760/cma.j.cn421203-20220727-00186.
ZHANG L, SONG SH, FU ZR. Clinical research advances of liver transplantation for patients with familial hypercholesterolemia[J]. Chin J Organ Transplant, 2023, 44(2): 112-116. DOI: 10.3760/cma.j.cn421203-20220727-00186.
|
[20] |
GULSOY KIRNAP N, KIRNAP M, BASCIL TUTUNCU N, et al. The curative treatment of familial hypercholesterolemia: liver transplantation[J]. Clin Transplant, 2019, 33(12): e13730. DOI: 10.1111/ctr.13730.
|
[21] |
AYTO RM, HUGHES DA, JEEVARATNAM P, et al. Long-term outcomes of liver transplantation in type 1 Gaucher disease[J]. Am J Transplant, 2010, 10(8): 1934-1939. DOI: 10.1111/j.1600-6143.2010.03168.x.
|
[22] |
LIU Y, LUO Y, XIA L, et al. The effects of liver transplantation in children with Niemann-Pick disease type B[J]. Liver Transpl, 2019, 25(8): 1233-1240. DOI: 10.1002/lt.25457.
|
[23] |
ARONSON SJ, JUNGE N, TRABELSI M, et al. Disease burden and management of Crigler-Najjar syndrome: report of a world registry[J]. Liver Int, 2022, 42(7): 1593-1604. DOI: 10.1111/liv.15239.
|
[24] |
SCHRÖDER H, JUNGE N, HERDEN U, et al. Outcome of liver transplantation and prevalence of liver fibrosis in Crigler-Najjar syndrome[J]. Clin Transplant, 2021, 35(4): e14219. DOI: 10.1111/ctr.14219.
|
[25] |
张文艳, 邓国宏. Crigler-Najjar综合征的治疗进展[J]. 临床肝胆病杂志, 2023, 39(4): 974-979. DOI: 10.3969/j.issn.1001-5256.2023.04.035.
ZHANG WY, DENG GH. Research advances in the treatment of Crigler-Najjar syndrome[J]. J Clin Hepatol, 2023, 39(4): 974-979. DOI: 10.3969/j.issn.1001-5256.2023.04.035.
|
[26] |
YOSHITOSHI EY, TAKADA Y, OIKE F, et al. Long-term outcomes for 32 cases of Wilson’s disease after living-donor liver transplantation[J]. Transplantation, 2009, 87(2): 261-267. DOI: 10.1097/TP.0b013e3181919984.
|
[27] |
BANDMANN O, WEISS KH, KALER SG. Wilson’s disease and other neurological copper disorders[J]. Lancet Neurol, 2015, 14(1): 103-113. DOI: 10.1016/S1474-4422(14)70190-5.
|
[28] |
POUJOIS A, WOIMANT F. Wilson’s disease: a 2017 update[J]. Clin Res Hepatol Gastroenterol, 2018, 42(6): 512-520. DOI: 10.1016/j.clinre.2018.03.007.
|
[29] |
GUILLAUD O, DUMORTIER J, SOBESKY R, et al. Long term results of liver transplantation for Wilson’s disease: experience in France[J]. J Hepatol, 2014, 60(3): 579-589. DOI: 10.1016/j.jhep.2013.10.025.
|
[30] |
SHEFLIN-FINDLING S, ANNUNZIATO RA, CHU J, et al. Liver transplantation for neonatal hemochromatosis: analysis of the UNOS database[J]. Pediatr Transplant, 2015, 19(2): 164-169. DOI: 10.1111/petr.12418.
|
[31] |
DAR FS, FARAJ W, ZAMAN MB, et al. Outcome of liver transplantation in hereditary hemochromatosis[J]. Transpl Int, 2009, 22(7): 717-724. DOI: 10.1111/j.1432-2277.2009.00863.x.
|
[32] |
GREENE CM, MARCINIAK SJ, TECKMAN J, et al. α1-Antitrypsin deficiency[J]. Nat Rev Dis Primers, 2016, 2: 16051. DOI: 10.1038/nrdp.2016.51.
|
[33] |
HOROUB R, SHAMSAEEFAR A, DEHGHANI M, et al. Liver transplant for primary hyperoxaluria type 1: results of sequential, combined liver and kidney, and preemptive liver transplant[J]. Exp Clin Transplant, 2021, 19(5): 445-449. DOI: 10.6002/ect.2019.0150.
|
[34] |
GUPTA A, SOMERS MJG, BAUM MA. Treatment of primary hyperoxaluria type 1[J]. Clin Kidney J, 2022, 15(Supplement_1): i9-i13. DOI: 10.1093/ckj/sfab232.
|
[35] |
DANA J, DEBRAY D, BEAUFRÈRE A, et al. Cystic fibrosis-related liver disease: clinical presentations, diagnostic and monitoring approaches in the era of CFTR modulator therapies[J]. J Hepatol, 2022, 76(2): 420-434. DOI: 10.1016/j.jhep.2021.09.042.
|
[36] |
UCHIDA H, SAKAMOTO S, SHIMIZU S, et al. Outcomes of liver transplantation for mitochondrial respiratory chain disorder in children[J]. Pediatr Transplant, 2021, 25(8): e14091. DOI: 10.1111/petr.14091.
|
[37] |
KIM JS, KIM KM, OH SH, et al. Liver transplantation for metabolic liver disease: experience at a living donor dominant liver transplantation center[J]. Pediatr Gastroenterol Hepatol Nutr, 2015, 18(1): 48-54. DOI: 10.5223/pghn.2015.18.1.48.
|
[38] |
孙丽莹, 朱志军, 魏林, 等. 肝移植治疗儿童遗传代谢性疾病42例[J]. 中华器官移植杂志, 2017, 38(6): 337-342. DOI: 10.3760/cma.j.issn.0254-1785.2017.06.004.
SUN LY, ZHU ZJ, WEI L, et al. Pediatric liver transplantation for metabolic liver disease: report of 42 cases[J]. Chin J Organ Transplant, 2017, 38(6): 337-342. DOI: 10.3760/cma.j.issn.0254-1785.2017.06.004.
|
[39] |
YAMADA N, INUI A, SANADA Y, et al. Pediatric liver transplantation for neonatal-onset Niemann-Pick disease type C: Japanese multicenter experience[J]. Pediatr Transplant, 2019, 23(5): e13462. DOI: 10.1111/petr.13462.
|
[40] |
中华医学会器官移植学分会, 中国医师协会器官移植医师分会. 中国儿童肝移植临床诊疗指南(2015版)[J]. 临床肝胆病杂志, 2016, 32(7): 1235-1244. DOI: 10.3969/j.issn.1001-5256.2016.07.001.
Branch of Organ Transplantation of Chinese Medical Association, Branch of Organ Transplant Physician of Chinese Medical Doctor Association. Clinical guidelines for pediatric liver transplantation in China(2015)[J]. J Clin Hepatol, 2016, 32(7): 1235-1244. DOI: 10.3969/j.issn.1001-5256.2016.07.001.
|
[41] |
SONG W, CHEN C, HUANG Y, et al. Living donor liver transplantation for pediatric patients with metabolic disease vs. deceased donation[J]. Asian J Surg, 2021, 44(4): 629-635. DOI: 10.1016/j.asjsur.2020.11.016.
|
[42] |
KASAHARA M, SAKAMOTO S, HORIKAWA R, et al. Living donor liver transplantation for pediatric patients with metabolic disorders: the Japanese multicenter registry[J]. Pediatr Transplant, 2014, 18(1): 6-15. DOI: 10.1111/petr.12196.
|
[43] |
KASAHARA M, SAKAMOTO S, FUKUDA A, et al. Marginal parental donors for pediatric living donor liver transplantation[J]. Curr Opin Organ Transplant, 2022, 27(4): 346-350. DOI: 10.1097/MOT.0000000000000990.
|
[44] |
AL-SHAMSI A, BAKER A, DHAWAN A, et al. Acute metabolic crises in maple syrup urine disease after liver transplantation from a related heterozygous living donor[J]. JIMD Rep, 2016, 30: 59-62. DOI: 10.1007/8904_2016_532.
|
[45] |
LIM C, TURCO C, BALCI D, et al. Auxiliary liver transplantation for cirrhosis: from APOLT to RAPID: a scoping review[J]. Ann Surg, 2022, 275(3): 551-559. DOI: 10.1097/SLA.0000000000005336.
|
[46] |
张文杰, 徐庆祥, 李国强, 等. 劈离式多米诺供肝辅助性肝移植的临床价值[J]. 中华消化外科杂志, 2022, 21(2): 287-294. DOI: 10.3760/cma.j.cn115610-20211230- 00694.
ZHANG WJ, XU QX, LI GQ, et al. Clinical value of split domino donor auxiliary liver transplantation[J]. Chin J Dig Surg, 2022, 21(2): 287-294. DOI: 10.3760/cma.j.cn115610-20211230-00694.
|
[47] |
DONG C, SONG Z, MENG X, et al. Successful living donor liver transplantation plus domino-auxiliary partial orthotopic liver transplantation for pediatric patients with metabolic disorders[J]. Pediatr Surg Int, 2020, 36(12): 1443-1450. DOI: 10.1007/s00383-020-04756-3.
|
[48] |
ZHOU GP, QU W, ZENG ZG, et al. Successful simultaneous subtotal splenectomy during left lobe auxiliary liver transplantation for portal inflow modulation and severe hypersplenism correction: a case report[J]. Front Med, 2022, 8: 818825. DOI: 10.3389/fmed.2021.818825.
|